I

Immugenia Inc.

4 employees

Immugenia is an early-stage immuno-oncology company.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Therapeutics

Date founded

2022

Funding rounds raised

I

Immugenia Inc. raised undisclosed on October 6, 2022

Investors: ACET Banque Nationale, Sherbrooke Innopole and adMare BioInnovations

FAQ